297. Predicting remission outcomes after subthreshold prolonged intermittent theta-burst stimulation in pharmacoresistant depression
Abstract Background Standard repetitive transcranial magnetic stimulation (rTMS) typically requires 20–30 treatment sessions for patients with major depressive disorder (MDD) who have not responded to at least one antidepressant administered at an adequate dose and duration. rTMS for the treatment of MDD was approved i...